Dr. Kristie Lynn Andrews, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 300 Audubon Rd, Howards Grove, WI 53083 Phone: 920-565-3991 |
David W Kisiolek, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 300 Audubon Rd, Howards Grove, WI 53083 Phone: 920-565-3991 Fax: 920-565-4404 |
David W. Kisiolek, O.d., S.c. Optometrist Medicare: Medicare Enrolled Practice Location: 300 Audubon Rd, Howards Grove, WI 53083 Phone: 920-565-3991 Fax: 920-565-4404 |
News Archive
It is known that women who undergo chemotherapy for breast cancer get an early menopause under age 40. Women can choose to have some eggs removed in advance of the treatment in order to preserve some chance of having a baby later, but that can be a difficult and complicated process. Now, however, there may be a medication to treat these women to avoid premature menopause. About 6% of women with breast cancer are diagnosed before age 40.
A study published in The Journal of Maternal-Fetal and Neonatal Medicine demonstrates that the fraction of fetal cell-free DNA (cfDNA) in maternal blood is unaffected by the mother's presumed risk for trisomy, offering support for the use of non-invasive prenatal testing (NIPT) for detecting genetic conditions such as Down syndrome in a broad patient population.
Transplant: A Gift for Life - a one-hour, Emmy Award-winning PBS documentary that includes Mayo Clinic transplant patients, their families, and doctors - will be distributed to public television stations nationwide this month. On Nov. 8, more than 60 PBS stations will air the program simultaneously through the PBS World channel, and many other PBS stations will air the program at various times (check local listings) over the next three years.
Medical device pioneer, Prescient Medical, Inc., announced today that it has received European CE Mark (Conformite Europeene) approval to commercialize its vProtect(TM) Luminal Shield Stent System. The device is now approved for use in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease.
Scientists worldwide have been working on the publicly available genomic sequences of the deadly E. coli O104 strain, which is causing the current health crisis in Germany and now spreading throughout Europe. To continue to speed the ongoing international efforts of researchers to assess and halt this growing epidemic, BGI and their collaborators at the University Medical Centre Hamburg-Eppendorf have now released their third version of the assembled genome, which includes new data from this E. coli O104.
› Verified 6 days ago